NR-47122金黄色葡萄球菌亚种.金黄色葡萄球菌、JE2、转座子突变体NE579(SAUSA300_1286)(突变细菌）
产品图片
货号/SKU
NR-47122
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质，其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类：美国、2
产品描述信息
NR-47122??Staphylococcus aureus subsp. aureus, JE2, Transposon Mutant NE579 (SAUSA300_1286)(Mutant Bacteria)|Staphylococcus aureus subsp. aureus|JE2, Transposon Mutant NE579 (SAUSA300_1286)|-60°C or colder|K Bayles, P Fey, NARSAAcknowledgment for publications should read "The following reagent was provided by the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for distribution by BEI Resources, NIAID, NIH: Staphylococcus aureus subsp. aureus, Strain JE2, Transposon Mutant NE579 (SAUSA300_1286), NR-47122."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Staphylococcus aureus (S. aureus) subsp. aureus, transposon mutant NE579 was derived from S. aureus subsp. aureus, strain JE2. Mutagenesis occurred through the use of the mariner-based transposon bursa aurealis resulting in an erythromycin-resistant deletion strain of JE2. S. aureus subsp. aureus, transposon mutant NE579 was created by disruption of SAUSA300_1286, which encodes for an aspartate kinase that catalyzes the formation of 4-phospho-L-aspartate from L-aspartate and ATP as part of the aspartate biosynthetic pathway.
S. aureus subsp. aureus, strain JE2 is a plasmid-cured derivative of strain LAC that was isolated in 2002 from a skin and soft tissue infection of an inmate in the Los Angeles County Jail in California, USA. Strain JE2 is a methicillin-resistant S. aureus (MRSA) strain and is a USA300 isolate. USA300 isolates have the same MLST profile (ST 8), SCCmec (subtype IV), agr group (I) and spa motif (MBQBLO) and typically carry the Panton-Valentine leukocidin (PVL) toxin genes and the arginine catabolic mobile element (ACME). USA300 is the most common cause of community-associated MRSA infection and an increasing cause of hospital-acquired infections.
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth containing 5 ?g/mL erythromycin supplemented with 10% glycerol.
The Nebraska Transposon Mutant Library (NTML) was constructed in the laboratories of Dr. Ken Bayles and Dr. Paul Fey at the University of Nebraska Medical Center. Additional information is available at the NTML website.
Staphylococcus aureus (S. aureus) subsp. aureus, transposon mutant NE579 was derived from S. aureus subsp. aureus, strain JE2. Mutagenesis occurred through the use of the mariner-based transposon bursa aurealis resulting in an erythromycin-resistant deletion strain of JE2. S. aureus subsp. aureus, transposon mutant NE579 was created by disruption of SAUSA300_1286, which encodes for an aspartate kinase that catalyzes the formation of 4-phospho-L-aspartate from L-aspartate and ATP as part of the aspartate biosynthetic pathway.
S. aureus subsp. aureus, strain JE2 is a plasmid-cured derivative of strain LAC that was isolated in 2002 from a skin and soft tissue infection of an inmate in the Los Angeles County Jail in California, USA. Strain JE2 is a methicillin-resistant S. aureus (MRSA) strain and is a USA300 isolate. USA300 isolates have the same MLST profile (ST 8), SCCmec (subtype IV), agr group (I) and spa motif (MBQBLO) and typically carry the Panton-Valentine leukocidin (PVL) toxin genes and the arginine catabolic mobile element (ACME). USA300 is the most common cause of community-associated MRSA infection and an increasing cause of hospital-acquired infections.
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth containing 5 ?g/mL erythromycin supplemented with 10% glycerol.
The Nebraska Transposon Mutant Library (NTML) was constructed in the laboratories of Dr. Ken Bayles and Dr. Paul Fey at the University of Nebraska Medical Center. Additional information is available at the NTML website.
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.在此限制上订单将在发货前发送到核苷酸以进行批准. 金黄色葡萄球菌（金黄色葡萄球菌）子. 金黄色葡萄球菌，转座子突变体NE579衍生自.金黄色葡萄球菌 subsp. 金黄色葡萄球菌，菌株JE2.通过使用制林仪基转蒸原体 Bursa Aurealis 通过使用诱变发生诱变. s.金黄色葡萄球菌 subsp. Trantposon突变体NE579是通过破坏SAUSA300_1286而产生的转座突变体NE579，其编码用于从L-天冬氨酸和ATP的形成4-磷-1-天冬氨酸作为天冬氨酸生物合成途径的一部分的形成. s.金黄色葡萄球菌 subsp. 金黄色葡萄球菌，菌株JE2是菌株LAC的质粒固化衍生物，其在美国加利福尼亚州加利福尼亚州洛杉矶县监狱的囚犯皮肤和软组织感染.菌株JE2是耐甲氧西林的.金黄色葡萄球菌（MRSA）菌株，是美国300孤立. USA300分离物具有相同的MLST型谱（ST 8），SCC MEC （亚型IV）， AGR 组（I）和 SPA 图案（MBQBLO ）通常携带粘合剂 - 华伦甘氨酸白细胞（PVL）毒素基因和精氨酸分解代谢移动元件（ACME）. USA300是社区相关的MRSA感染的最常见原因以及越来越多的医院收养的感染原因. 每个小瓶在含有5μg/ ml红霉素的胰蛋白酶肉汤中含有大约0.5毫升的细菌培养物补充有10个％甘油. ntml 网站提供了附加信息.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立，旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中，可以监控科学界对这些材料的访问和使用，并确保试剂的质量控制。
除了为传染病界提供材料外，BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势，包括安全存储、社区访问和分发；同时保护存款人的知识产权。只要有需要，BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月， ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料，包括由其他政府支持的研究项目存放的材料，将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中，涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2024-09-12
2019-05-08
2024-05-19
2022-04-01
2024-02-29
2024-05-19
2022-04-01
2022-04-01
2022-04-01
2021-12-13
2021-12-02
2022-04-01
2022-04-01
2023-12-13
2022-04-01